Journal articles on the topic 'Structure Activity Relationship studies'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Structure Activity Relationship studies.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Skalkos, Dimitris, James A. Hampton, Rick W. Keck, Miriam Wagoner, and Steven H. Selman. "IMINIUM SALT BENZOCHLORINS: STRUCTURE-ACTIVITY RELATIONSHIP STUDIES." Photochemistry and Photobiology 59, no. 2 (1994): 175–81. http://dx.doi.org/10.1111/j.1751-1097.1994.tb05019.x.
Full textGerman, Nadezhda A., Ann M. Decker, Brian P. Gilmour, Brian F. Thomas, and Yanan Zhang. "Truncated Orexin Peptides: Structure–Activity Relationship Studies." ACS Medicinal Chemistry Letters 4, no. 12 (2013): 1224–27. http://dx.doi.org/10.1021/ml400333a.
Full textPatil, Nitin A., K. Johan Rosengren, Frances Separovic, John D. Wade, Ross A. D. Bathgate, and Mohammed Akhter Hossain. "Relaxin family peptides: structure-activity relationship studies." British Journal of Pharmacology 174, no. 10 (2017): 950–61. http://dx.doi.org/10.1111/bph.13684.
Full textMa, Anqi, Wenyu Yu, Yan Xiong, Kyle V. Butler, Peter J. Brown, and Jian Jin. "Structure–activity relationship studies of SETD8 inhibitors." MedChemComm 5, no. 12 (2014): 1892–98. http://dx.doi.org/10.1039/c4md00317a.
Full textKo, Horng-Huey, Lo-Ti Tsao, Kun-Lung Yu, Cheng-Tsung Liu, Jih-Pyang Wang, and Chun-Nan Lin. "Structure–activity relationship studies on chalcone derivatives." Bioorganic & Medicinal Chemistry 11, no. 1 (2003): 105–11. http://dx.doi.org/10.1016/s0968-0896(02)00312-7.
Full textMurthi, Krishna K., Marja Dubay, Christopher McClure, et al. "Structure–activity relationship studies of flavopiridol analogues." Bioorganic & Medicinal Chemistry Letters 10, no. 10 (2000): 1037–41. http://dx.doi.org/10.1016/s0960-894x(00)00156-6.
Full textTsukano, Chihiro, and Makoto Sasaki. "Structure–activity relationship studies of gymnocin-A." Tetrahedron Letters 47, no. 38 (2006): 6803–7. http://dx.doi.org/10.1016/j.tetlet.2006.07.081.
Full textFuchs, James R., Bulbul Pandit, Deepak Bhasin, et al. "Structure–activity relationship studies of curcumin analogues." Bioorganic & Medicinal Chemistry Letters 19, no. 7 (2009): 2065–69. http://dx.doi.org/10.1016/j.bmcl.2009.01.104.
Full textCheuka, Peter Mubanga, Diego Gonzalez Cabrera, Tanya Paquet, and Kelly Chibale. "Structure–activity relationship studies of antiplasmodial aminomethylthiazoles." Bioorganic & Medicinal Chemistry Letters 24, no. 22 (2014): 5207–11. http://dx.doi.org/10.1016/j.bmcl.2014.09.071.
Full textWiker, Franziska, Nils Hauck, Stephanie Grond, and Bertolt Gust. "Caprazamycins: Biosynthesis and structure activity relationship studies." International Journal of Medical Microbiology 309, no. 5 (2019): 319–24. http://dx.doi.org/10.1016/j.ijmm.2019.05.004.
Full textKlopman, G., S. Wang, M. R. Jacobs, and J. J. Ellner. "Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies." Antimicrobial Agents and Chemotherapy 37, no. 9 (1993): 1807–15. http://dx.doi.org/10.1128/aac.37.9.1807.
Full textGupta, Satya. "Quantitative Structure-Activity Relationship Studies on Cholecystokinin Antagonists." Current Pharmaceutical Design 8, no. 2 (2002): 111–24. http://dx.doi.org/10.2174/1381612023396500.
Full textGupta, Satya, and Anantha Nagappa. "Quantitative Structure-Activity Relationship Studies on Cholecystokin Antagonists." Medicinal Chemistry Reviews - Online 1, no. 3 (2004): 349–50. http://dx.doi.org/10.2174/1567203043401680.
Full textNeves, Ana R., Marta Correia-da-Silva, Emília Sousa, and Madalena Pinto. "Structure–activity relationship studies for multitarget antithrombotic drugs." Future Medicinal Chemistry 8, no. 18 (2016): 2305–55. http://dx.doi.org/10.4155/fmc-2015-0020.
Full textNelson, Derek W., Kathy Sarris, Douglas M. Kalvin, et al. "Structure−Activity Relationship Studies onN′-Aryl Carbohydrazide P2X7Antagonists." Journal of Medicinal Chemistry 51, no. 10 (2008): 3030–34. http://dx.doi.org/10.1021/jm701516f.
Full textBurden, Frank R. "Quantitative Structure−Activity Relationship Studies Using Gaussian Processes." Journal of Chemical Information and Computer Sciences 41, no. 3 (2001): 830–35. http://dx.doi.org/10.1021/ci000459c.
Full textGupta, S. P. "Quantitative Structure-Activity Relationship Studies on Anticancer Drugs." Chemical Reviews 94, no. 6 (1994): 1507–51. http://dx.doi.org/10.1021/cr00030a003.
Full textJaeger, EP, PC Jurs, and TR Stouch. "Structure-activity relationship studies of retinoid cancer inhibition." European Journal of Medicinal Chemistry 28, no. 4 (1993): 275–90. http://dx.doi.org/10.1016/0223-5234(93)90145-5.
Full textMurugesan, Dinakaran, Marcel Kaiser, Karen L. White, et al. "Structure–Activity Relationship Studies of Pyrrolone Antimalarial Agents." ChemMedChem 8, no. 9 (2013): 1537–44. http://dx.doi.org/10.1002/cmdc.201300177.
Full textSuryanarayana, M. V. S., K. S. Pandey, Shri Prakash, et al. "Structure-Activity Relationship Studies with Mosquito Repellent Amides." Journal of Pharmaceutical Sciences 80, no. 11 (1991): 1055–57. http://dx.doi.org/10.1002/jps.2600801111.
Full textIyamu, Iredia D., Yingzhao Zhao, Prakash T. Parvatkar, et al. "Structure-activity and structure-property relationship studies of spirocyclic chromanes with antimalarial activity." Bioorganic & Medicinal Chemistry 57 (March 2022): 116629. http://dx.doi.org/10.1016/j.bmc.2022.116629.
Full textTsai, C. C., P. J. Durand, K. J. McCabe, and J. W. Baker. "Structure-activity relationship studies of nucleoside analogs with anti-HIV activity." Antiviral Research 30, no. 1 (1996): A29. http://dx.doi.org/10.1016/0166-3542(96)80263-4.
Full textRajwade, R. P. "Quantitative structure–activity relationship (QSAR) studies on antitumor activity: glutamine analogues." New Biotechnology 27 (April 2010): S22—S23. http://dx.doi.org/10.1016/j.nbt.2010.01.015.
Full textGalas, M. C., M. F. Lignon, M. Rodriguez, et al. "Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity." American Journal of Physiology-Gastrointestinal and Liver Physiology 254, no. 2 (1988): G176—G182. http://dx.doi.org/10.1152/ajpgi.1988.254.2.g176.
Full textSubramanian, Santhosh, Nam-Soo Kim, Pillaiyar Thanigaimalai, et al. "Structure–activity relationship studies of novel arylsulfonylimidazolidinones for their anticancer activity." European Journal of Medicinal Chemistry 46, no. 8 (2011): 3258–64. http://dx.doi.org/10.1016/j.ejmech.2011.04.042.
Full textChang-Ying, Chen, Ding Xiao-Qin, and Feng Shan. "Studies on Electronic Structure and Structure-Activity Relationship of Ciguatoxin(CTX)." Acta Physico-Chimica Sinica 16, no. 04 (2000): 307–11. http://dx.doi.org/10.3866/pku.whxb20000404.
Full textLu, X., D. Lu, M. Scully, and V. Kakkar. "Structure-Activity Relationship Studies on ADAM Protein-Integrin Interactions." Cardiovascular & Hematological Agents in Medicinal Chemistry 5, no. 1 (2007): 29–42. http://dx.doi.org/10.2174/187152507779315822.
Full textBoyle, Craig, and Anandan Palani. "Structure-Activity Relationship Studies: M2 and CCR5 Receptor Antagonists." Current Topics in Medicinal Chemistry 3, no. 10 (2003): 1155–69. http://dx.doi.org/10.2174/1568026033452032.
Full textMilojković-Opsenica, Dušanka, Filip Andrić, Sandra Šegan, Jelena Trifković, and Živoslav Tešić. "Thin-layer chromatography in quantitative structure-activity relationship studies." Journal of Liquid Chromatography & Related Technologies 41, no. 6 (2018): 272–81. http://dx.doi.org/10.1080/10826076.2018.1447892.
Full textBernardo, Paul H., Kah-Fei Wan, Thirunavukkarasu Sivaraman, et al. "Structure−Activity Relationship Studies of Phenanthridine-Based Bcl-XLInhibitors." Journal of Medicinal Chemistry 51, no. 21 (2008): 6699–710. http://dx.doi.org/10.1021/jm8005433.
Full textLiu, Xiaofan, Yanping Wang, Richard I. Duclos, and George A. O’Doherty. "Stereochemical Structure Activity Relationship Studies (S-SAR) of Tetrahydrolipstatin." ACS Medicinal Chemistry Letters 9, no. 3 (2018): 274–78. http://dx.doi.org/10.1021/acsmedchemlett.8b00050.
Full textKnight, Jennifer L., та Charles L. Brooks. "Multisite λ Dynamics for Simulated Structure–Activity Relationship Studies". Journal of Chemical Theory and Computation 7, № 9 (2011): 2728–39. http://dx.doi.org/10.1021/ct200444f.
Full textLiu, S. P., Q. C. Huang, Y. Q. Tang, and Z. W. Qi. "Studies of the structure-activity relationship of TTI inhibitor." Acta Crystallographica Section A Foundations of Crystallography 49, s1 (1993): c153. http://dx.doi.org/10.1107/s010876737809563x.
Full textWu, Chunlei, Zhengyin Pan, Guiyang Yao, Wei Wang, Lijing Fang, and Wu Su. "Synthesis and structure–activity relationship studies of teixobactin analogues." RSC Advances 7, no. 4 (2017): 1923–26. http://dx.doi.org/10.1039/c6ra26567g.
Full textOzkan, Refik, and Nurten Tezer. "Structure–activity relationship studies on aza analogues of illudins." Journal of Molecular Structure: THEOCHEM 572, no. 1-3 (2001): 15–24. http://dx.doi.org/10.1016/s0166-1280(01)00574-7.
Full textBraga, R. S., R. Vendrame та D. S. Galvão. "Structure−Activity Relationship Studies of Substituted 17α-Acetoxyprogesterone Hormones". Journal of Chemical Information and Computer Sciences 40, № 6 (2000): 1377–85. http://dx.doi.org/10.1021/ci000454f.
Full textGupta, S. P. "QSAR (quantitative structure-activity relationship) studies on local anesthetics." Chemical Reviews 91, no. 6 (1991): 1109–19. http://dx.doi.org/10.1021/cr00006a001.
Full textCheon, Seung Hoon, Joon Suck Park, Joon Yeol Lee, et al. "Structure-activity relationship studies of isoquinolinone type anticancer agent." Archives of Pharmacal Research 24, no. 4 (2001): 276–80. http://dx.doi.org/10.1007/bf02975091.
Full textMisra, Milind, Qing Shi, Xiaocong Ye, et al. "Quantitative structure–activity relationship studies of threo-methylphenidate analogs." Bioorganic & Medicinal Chemistry 18, no. 20 (2010): 7221–38. http://dx.doi.org/10.1016/j.bmc.2010.08.034.
Full textHermkens, Pedro H. H., Harry C. J. Ottenheijm, Jane M. L. van der Werf-Pieters, Chris L. E. Broekkamp, Thijs de Boer, and Jan W. van Nispen. "CCK-A Agonists: Endeavours involving structure-activity relationship studies." Recueil des Travaux Chimiques des Pays-Bas 112, no. 2 (2010): 95–106. http://dx.doi.org/10.1002/recl.19931120205.
Full textMurthi, Krishna K., Marja Dubay, Christopher McClure, et al. "ChemInform Abstract: Structure-Activity Relationship Studies of Flavopiridol Analogues." ChemInform 31, no. 35 (2010): no. http://dx.doi.org/10.1002/chin.200035118.
Full textXue, Chao-Bin, Wan-Chun Luo, Qi Ding, Shou-Zhu Liu, and Xing-Xiang Gao. "Quantitative structure–activity relationship studies of mushroom tyrosinase inhibitors." Journal of Computer-Aided Molecular Design 22, no. 5 (2008): 299–309. http://dx.doi.org/10.1007/s10822-008-9187-6.
Full textXu, Lu, Jia-An Yang, and Ya-Ping Wu. "Effective Descriptions of Molecular Structures and the Quantitative Structure−Activity Relationship Studies." Journal of Chemical Information and Computer Sciences 42, no. 3 (2002): 602–6. http://dx.doi.org/10.1021/ci010092r.
Full textGuerrero, Ligia, Julián Castillo, Mar Quiñones, et al. "Inhibition of Angiotensin-Converting Enzyme Activity by Flavonoids: Structure-Activity Relationship Studies." PLoS ONE 7, no. 11 (2012): e49493. http://dx.doi.org/10.1371/journal.pone.0049493.
Full textAkester, Jessica N., Paul Njaria, Aloysius Nchinda, et al. "Synthesis, Structure–Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity." ACS Infectious Diseases 6, no. 7 (2020): 1951–64. http://dx.doi.org/10.1021/acsinfecdis.0c00252.
Full textIndra, Bachtiar, Kimihiro Matsunaga, Osamu Hoshino, Masaji Suzuki, Hiromichi Ogasawara та Yasushi Ohizumi. "Structure–activity relationship studies with (±)-nantenine derivatives for α1-adrenoceptor antagonist activity". European Journal of Pharmacology 437, № 3 (2002): 173–78. http://dx.doi.org/10.1016/s0014-2999(02)01303-1.
Full textMoreira, Joana, Lucilia Saraiva, Madalena M. Pinto, and Honorina Cidade. "Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies." European Journal of Medicinal Chemistry 192 (April 2020): 112177. http://dx.doi.org/10.1016/j.ejmech.2020.112177.
Full textWang, Peng, Lin-Feng Li, Qing-Yin Wang, Lu-Qing Shang, Pei-Yong Shi, and Zheng Yin. "Anti-Dengue-Virus Activity and Structure-Activity Relationship Studies of Lycorine Derivatives." ChemMedChem 9, no. 7 (2014): 1522–33. http://dx.doi.org/10.1002/cmdc.201300505.
Full textDu, Juan, Lili Xi, Beilei Lei, et al. "Structure-based quantitative structure-activity relationship studies of checkpoint kinase 1 inhibitors." Journal of Computational Chemistry 31, no. 15 (2010): 2783–93. http://dx.doi.org/10.1002/jcc.21571.
Full textJavor, Sacha, and Jean-Louis Reymond. "Structure-Activity Relationship Studies in Single-Site Esterase Peptide Dendrimers." Israel Journal of Chemistry 49, no. 1 (2009): 129–36. http://dx.doi.org/10.1560/ijc.49.1.129.
Full text